BioTech
TMO

Thermo Fisher raises bid for Qiagen to 43 eur/shr

Contributor
Caroline Copley Reuters
Published
Credit: REUTERS/Henry Nicholls

Thermo Fisher Scientific said on Thursday it had decided to raise its bid for Qiagen to 43 euros ($49.06) per share to reflect the German genetic test maker's improved business prospects since the coronavirus pandemic.

BERLIN, July 16 (Reuters) - Thermo Fisher Scientific TMO.N said on Thursday it had decided to raise its bid for Qiagen QIA.DE to 43 euros ($49.06) per share to reflect the German genetic test maker's improved business prospects since the coronavirus pandemic.

Thermo Fisher's cash offer represents a 35% premium to Qiagen's closing price on March 2, the two companies said in a statement.

($1 = 0.8764 euros)

(Reporting by Caroline Copley Editing by Michelle Martin)

((Caroline.Copley@thomsonreuters.com; +49 30 2888 5214; Reuters Messaging: caroline.copley.thomsonreuters.com@reuters.net))

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

TMO

Other Topics

US Markets

Latest Technology Videos

See more videos

Reuters

Reuters, the news and media division of Thomson Reuters, is the world’s largest international multimedia news provider reaching more than one billion people every day. Reuters provides trusted business, financial, national, and international news to professionals via Thomson Reuters desktops, the world's media organizations, and directly to consumers at Reuters.com and via Reuters TV.

Learn More

More from Reuters

Explore BioTech

Explore

Most Popular